Logo image
Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology
Journal article   Open access   Peer reviewed

Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology

Eric J Devor, Henry D Reyes, Jesus Gonzalez-Bosquet, Akshaya Warrier, Susan A Kenzie, Nonye V Ibik, Marina D Miller, Brandon M Schickling, Michael J Goodheart, Kristina W Thiel, …
International journal of gynecological cancer, Vol.27(4), pp.784-790
05/2017
DOI: 10.1097/IGC.0000000000000957
PMCID: PMC5405019
PMID: 28375929
url
https://www.ncbi.nlm.nih.gov/pmc/articles/5405019View
Open Access

Abstract

Expression of the trophoblast-specific gene placenta-specific protein 1 (PLAC1) has been detected in a wide variety of cancers. However, to date, PLAC1 expression has not been shown in cervical cancer. We have carried out a preliminary study that shows for the first time that PLAC1 is expressed in cervical cancers. A total of 16 primary cervical tumors were obtained from patients shown to be human papillomavirus (HPV) 16/18 positive. Total cellular RNA, genomic DNA, and total protein were purified from each tumor. These materials were then used to determine PLAC1 expression, TP53 mutation status, and p53 expression. The PLAC1 expression was demonstrated in all 16 primary cervical tumors. The highest levels of expression were found in the more aggressive squamous and adenosquamous histologic types compared with adenocarcinomas. Moreover, the proportion of total PLAC1 message coming from the P1 promoter, also termed the distal or cancer promoter, was significantly greater in the more aggressive squamous and adenosquamous histologic types compared with adenocarcinomas. Finally, in spite of all 16 tumors being HPV-16/18 positive, 3 of 8 squamous cell cancers and 2 of 5 adenocarcinomas expressed wild-type p53 protein. Consistent with the recently shown suppression of the PLAC1P1 promoter by wild-type p53, these p53 positive tumors displayed among the lowest P1-specific PLAC1 expression levels. The PLAC1 expression has been demonstrated for the first time in cervical cancers. This preliminary study has further revealed a complex relationship between PLAC1 expression, cervical cancer histologic type, p53, and HPV type that requires further investigation.
Tumor Suppressor Protein p53 - biosynthesis DNA, Neoplasm - metabolism Humans Middle Aged Pregnancy Proteins - genetics Uterine Cervical Neoplasms - pathology RNA, Neoplasm - metabolism Tumor Suppressor Protein p53 - genetics Papillomavirus Infections - pathology Human papillomavirus 16 - isolation & purification Uterine Cervical Neoplasms - metabolism Aged, 80 and over Adult Female Papillomavirus Infections - virology Human papillomavirus 18 - genetics Promoter Regions, Genetic Uterine Cervical Neoplasms - genetics Pregnancy Proteins - biosynthesis Papillomavirus Infections - genetics Human papillomavirus 18 - isolation & purification Papillomavirus Infections - metabolism RNA, Neoplasm - genetics Uterine Cervical Neoplasms - virology Aged DNA, Neoplasm - genetics Human papillomavirus 16 - genetics

Details

Metrics

Logo image